Range
5.37 - 5.52
Vol / Avg.
57.6K/55.8K
Div / Yield
-
52 Wk
5.25 - 12.44
Mkt Cap
81.2M
Payout Ratio
-
Open
5.48
P/E
-
EPS
-0.61
Shares
15M
Outstanding
15M
Total Float
-
Benzinga - 4 days ago
Benzinga - May 13, 2021, 6:52AM
Benzinga - May 12, 2021, 4:12PM
Benzinga - May 10, 2021, 6:12AM
Benzinga - Mar 26, 2021, 12:00PM
Benzinga - Mar 24, 2021, 4:03PM
Benzinga - Dec 15, 2020, 4:02PM
Benzinga - Dec 8, 2020, 6:10AM
load more
Sector: Health Care.Industry: Biotechnology
Celyad Oncology is a biopharmaceutical company, specialized in cell therapy. It develops technologies and treatments to treat severe diseases with poor prognosis. The company focuses on Immuno oncology, Cardiology, and Medical devices. Its main product candidates include CAR-T and C-Cure. The firm has CYAD-01 and CYAD-02 programs in pipeline. The company owns trademarks and service marks including CELYAD, C-CATH, C_CURE, CATH and C-CATHez and CARDIO 3 BIOSCIENCES. The firm has Cardiology and Immuno-oncology operating segments.

Earnings

see more
H1 2021Est.ActualSurprise
EPS
(EXPECTED)2021-09-08
REV
Q1 2021Est.ActualSurprise
EPS-0.740
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
CYADCelyad Oncology-1.11%81.2M

Celyad Oncology Frequently Asked Questions

Q

How do I buy Celyad Oncology (CYAD) stock?

A

You can purchase shares of Celyad Oncology (NASDAQ: CYAD) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Celyad Oncology's (CYAD) competitors?

A

Other companies in Celyad Oncology’s space includes: PolarityTE (NASDAQ:PTE), Allena Pharmaceuticals (NASDAQ:ALNA), Cleveland BioLabs (NASDAQ:CBLI), Addex Therapeutics (NASDAQ:ADXN) and Monopar Therapeutics (NASDAQ:MNPR).

Q

What is the target price for Celyad Oncology (CYAD) stock?

A

The latest price target for Celyad Oncology (NASDAQ: CYAD) was reported by HC Wainwright & Co. on May 10, 2021. The analyst firm set a price target for 17.00 expecting CYAD to rise to within 12 months (a possible 214.26% upside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Celyad Oncology (CYAD)?

A

The stock price for Celyad Oncology (NASDAQ: CYAD) is $5.4095 last updated Today at 7:20:56 PM.

Q

Does Celyad Oncology (CYAD) pay a dividend?

A

There are no upcoming dividends for Celyad Oncology.

Q

When is Celyad Oncology (NASDAQ:CYAD) reporting earnings?

A
Celyad Oncology’s H1 earnings are confirmed for after-market on September 8, 2021.
Q

Is Celyad Oncology (CYAD) going to split?

A

There is no upcoming split for Celyad Oncology.

Q

What sector and industry does Celyad Oncology (CYAD) operate in?

A

Celyad Oncology is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.